Navigation Links
Surgical Theater, LLC sells first Surgical Rehearsal Platform to UH Case Medical Center
Date:11/28/2012

Surgical Theater, LLC, creator of the Selman Surgical Rehearsal Platform (SRP), has made the first sale of its groundbreaking technology to University Hospitals (UH) Case Medical Center in Cleveland, one of the most respected research/teaching hospitals in America. Physicians at the medical center have been instrumental in the development of Surgical Theater, so it is fitting that the institution becomes the first to own the unique, 3D imaging rehearsal platform.

Using standard scanned images from any patient, the SRP generates 3D patient specific and accurate models of interactions between life-like tissue and surgical instruments. The tissue responds "realistically" to actions taken by the surgeon, thus allowing accurate pre-surgery planning and rehearsal. The unique software utilizes flight simulator technology to permit remote connection of multiple SRPs; participants anywhere in the world can simultaneously work together and practice the same case with real-time feedback and collaborate on the planning of a specific surgery case.

Dr. Warren Selman, Chairman, Department of Neurological Surgery at UH Case Medical Center and Case Western Reserve University School of Medicine in Cleveland, is a co-originator of the Platform's development. Not long ago, a random conversation at a coffee shop between Dr. Selman and the now-CEO of Surgical Theater was the beginning of the SRP's development.

"We're thrilled to have our first sale be to the institution that has been our partner in developing the SRP. The innovative spirit and trailblazing research in this academic medical center have inspired us from the inception of Surgical Theater," said Moty Avisar, President and CEO, Surgical Theater.

The Neurological Surgery Department at UH Case Medical Center has been using the SRP for over two years, and provided clinical insight to the company during its development. Now, with the purchase of the Platform, it will be used for clinical studies to document the value of pre-surgical rehearsal, and for resident and fellow education. Following US Food and Drug Administration (FDA) approval, anticipated in the first quarter of next year, the Platform will be extended to routine patient care.

"Having been involved with the creation of this new technology, I've seen first-hand the potential for it to radically change neurosurgical training and benefit patient care. I'm thrilled that with the purchase by UH our physicians and neurosurgery residents will benefit first from the innovation," said Dr. Selman, who is also Neurosurgeon-in-Chief at University Hospitals and the Harvey Huntington Brown Jr., Professor at Case Western Reserve University School of Medicine.

Surgical Theater launched the Platform at the Congress of Neurological Surgeons Annual Meeting in early October after receiving their first broad patent approval and submitting their application to the FDA.

"To have our first sale so quickly after launch, and with the forecast of more than five additional sales in coming months, is gratifying after so many months of hard work," said Avisar. "We're excited first and foremost at the potential for improved patient outcomes, and at the same time anticipate this sale is the beginning of great things for our company."

Peter R. Brumbergs Named CFO

Along with the initial sale and the patent approval, interest in the company has emerged from a number of investors. To help manage these investment opportunities as well as company finances, Surgical Theater recently named Peter R. Brumbergs as its first Chief Financial Officer. Brumbergs is a savvy business leader with more than 35 years of experience at Fortune 500, middle-market and entrepreneurial companies.

Most recently Brumbergs was CFO of U.S. Endoscopy, a medical device manufacturer with world-wide distribution, and was a member of the executive team that led and closed the sale of U.S. Endoscopy to Steris Corporation. He was also instrumental in developing and implementing growth initiatives that resulted in sales quadrupling and operating income increasing by over 40 times.

"We are pleased to welcome Peter to our growing team of business and technology experts," Avisar said. "Peter's business savvy and national contacts in the medical equipment industry will be extremely important as we continue to grow."


'/>"/>

Contact: George Stamatis
george.stamatis@uhhospitals.org
216-844-3667
University Hospitals Case Medical Center
Source:Eurekalert

Related biology news :

1. Global Surgical Devices Market Growth Driven by Improving Standards of Living and Longer Life Expectancies, Research Shows
2. Researchers discover non-surgical test for brain cancer
3. Pre-surgical steps for eye surgery are standardized through JoVEs video publication
4. Kessler Foundation implements Ekso Bionics first commercial robotic exoskeleton
5. Research reveals first evidence of hunting by prehistoric Ohioans
6. First model of how buds grow into leaves
7. American College of Rheumatology releases first classification criteria for polymyalagia rheumatica
8. Ottawa researchers to lead world-first clinical trial of stem cell therapy for septic shock
9. First complete full genetic map of promising energy crop
10. FirstMark Announces New Hire Jay Houtman as Southeast Regional Sales Manager
11. FirstMark Exhibiting at the Inaugural Atlanta Clinical Cardiology Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2017)... , April 13, 2017 According to a ... Identity Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment ... the IAM Market is expected to grow from USD 14.30 Billion in ... Rate (CAGR) of 17.3%. ... MarketsandMarkets Logo ...
(Date:4/6/2017)... Forecasts by Product Type (EAC), ... End-Use (Transportation & Logistics, Government & Public Sector, Utilities ... Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), ... you looking for a definitive report on the $27.9bn ... ...
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... (PRWEB) , ... October 12, ... ... ) has launched Rosalind™, the first-ever genomics analysis platform specifically designed for ... complexity. Named in honor of pioneering researcher Rosalind Franklin, who made a ...
(Date:10/11/2017)... USA (PRWEB) , ... October 11, 2017 , ... ComplianceOnline’s ... take place on 7th and 8th June 2018 in San Francisco, CA. The Summit ... as well as several distinguished CEOs, board directors and government officials from around the ...
(Date:10/11/2017)... ... 2017 , ... Disappearing forests and increased emissions are the main causes of ... year. Especially those living in larger cities are affected by air pollution related diseases. ... most pollution-affected countries globally - decided to take action. , “I knew I had ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give it ... Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). ...
Breaking Biology Technology: